ALERTS, HOT STOCKS & CHARTS

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Academy Sports + Outdoors Supports Military Families This School Year In an inspiring initiative aimed at supporting military families, Academy Sports + Outdoors has partnered with Operation Homefront to provide essential school supplies for students heading back to class. As the back-to-school season approaches, these organizations are ensuring that military children...

Repligen Corp Highlights Strong Q4 Performance Repligen Corp (NASDAQ: RGEN) has recently reported its fourth-quarter earnings, showcasing an adjusted EPS of 44 cents. This is a slight decrease compared to the previous year's 48 cents but notably beats analysts’ consensus estimates of 41 cents. Sales Performance and Market Outlook The company reported sales hitting...

Propanc Biopharma's Recent Developments and Strategic Vision Propanc Biopharma, Inc. (NASDAQ: PPCB), a biopharmaceutical firm centered on innovations in cancer treatment, recently shared its year-end updates and strategic plans. As the financial year concluded on June 30, 2025, notable gains in the Company’s financial health have paved the way for exciting advancements....

MIAX Expands Leadership Team to Drive Market Growth Miami International Holdings, Inc. (NYSE: MIAX) is excited to unveil the new appointments of Shelly Brown and Joseph W. Ferraro III as part of its commitment to strategic growth in the futures market. These moves are aimed at enhancing leadership within MIAX Futures™, a core component of its expanding offerings in...

Fortis Inc. Announces Upcoming Shareholder Dividends Fortis Inc. has officially declared dividends that are set to benefit its shareholders on March 1, 2025. This announcement is a key development for shareholders holding various classes of shares with specific dividends attached. The established record date for these dividends is February 18, 2025, marking an important...